Ciprofloxacin Solution
Product Images NDC 67296-1703

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 67296-1703). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel10ml (Cartonlabel10ml)

Cartonlabel10ml (Cartonlabel10ml)
This text provides information on an ophthalmic solution containing ciprofloxacin hydrochloride. It includes details on the active ingredient, instructions for use, precautions, dosage, and storage information. The solution is for topical ophthalmic use only, and users are advised not to touch the dropper tip to avoid contamination. The product is distributed by Leading Pharma, LLC and manufactured by FDC Limited in India. Additionally, the text mentions the sterile nature of the solution and provides a caution to only use gentle pressure when dispensing the drops.*
FDA Label Image

Cartonlabel2point5ml (Cartonlabel2point5ml)

Cartonlabel2point5ml (Cartonlabel2point5ml)
This text appears to be a product description for an ophthalmic solution containing ciprofloxacin. The solution contains 3.5 mg ciprofloxacin hydrochloride, equivalent to 3 mg ciprofloxacin base, along with benzalkonium chloride as a preservative. The instructions include snapping off the dust cover, storing at 25°C, and using a colored cap for dispensing. It is advised not to touch the dropper tip to any surface to prevent contamination. The product is distributed by Leading Pharma, LLC in Fairfield, NJ. It is for topical ophthalmic use only and should be kept protected from light until use.*
FDA Label Image

Cartonlabel5ml (Cartonlabel5ml)

FDA Label Image

Containerlabel10ml (Containerlabel10ml)

Containerlabel10ml (Containerlabel10ml)
This is a description of Ciprofloxacin Ophthalmic Solution USP 0.3%, a sterile eye drop solution used for ophthalmic purposes. Each mL contains 3.5mg of the active ingredient, ciprofloxacin hydrochloride, which is equivalent to 3mg of ciprofloxacin base. The solution also contains a preservative (benzalkonium chloride 0.006%) and inactive ingredients such as sodium acetate, acetic acid, mannitol, edetate disodium, and more. The product is for topical ophthalmic use only, and dosage instructions can be found in the enclosed insert. It should be stored at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). The product is distributed by Leading Pharma, LLC and manufactured by FDC Limited in India.*
FDA Label Image

Containerlabel2point5ml (Containerlabel2point5ml)

Containerlabel2point5ml (Containerlabel2point5ml)
This is a description of Ciprofloxacin Ophthalmic Solution USP 0.3%. It is an ophthalmic medication used for topical ophthalmic use only. Each mL contains 3.5 mg of ciprofloxacin as the active ingredient. The solution is sterile and contains benzalkonium chloride as a preservative. The medication is manufactured and distributed by Pharma LLC in Fairfield, NJ. It should be stored at room temperature (25°C/77°F) and protected from light until contents are used. Full dosage instructions can be found in the enclosed insert.*
FDA Label Image

Containerlabel5ml (Containerlabel5ml)

Containerlabel5ml (Containerlabel5ml)
This is a description for Ciprofloxacin Ophthalmic Solution USP 0.3%. It is a sterile prescription medication indicated for topical ophthalmic use. Each mL contains 3.5 mg of ciprofloxacin as base. The solution is preserved with benzalkonium chloride. The inactive ingredients include sodium acetate, acetic acid, mannitol, edetate disodium, hydrochloric acid, and/or sodium hydroxide, along with water for injection. The usual dosage must be followed as specified in the enclosed insert. The solution is to be stored at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). Distributed by Leading Pharma, LLC and manufactured by FDC Limited in Maharashtra, India. The product should be protected from light.*
FDA Label Image

Ciprofloxacin Hydrochloride (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 01)

Ciprofloxacin Hydrochloride (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 01)
This text refers to carboxylic acid functional group, denoted as COOH. Carboxylic acids are organic compounds containing a carboxyl group, which consists of a carbonyl group (C=O) and a hydroxyl group (-OH) attached to the same carbon atom. Carboxylic acids are commonly found in various natural sources and are important building blocks in organic chemistry.*
FDA Label Image

Fig 1 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 02)

FDA Label Image

Fig 2 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 03)

FDA Label Image

Fig 2 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 04)

FDA Label Image

Fig 4 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 05)

FDA Label Image

Fig 5 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 06)

FDA Label Image

Fig 6 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 07)

FDA Label Image

Fig 7 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 08)

FDA Label Image

Fig 8 (Dc84116e Aaa2 4ce5 A382 729fb6d4af6e 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.